QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Onartuzumab | ONARTUZUMAB ( 奥那妥组单抗 ) | 1133766-06-9 |
| Indatuximab Ravtansine | Indatuximab Ravtansine | 1238517-16-2 |
| Quilizumab | Quilizumab | 1228538-47-3 |
| Placulumab | Placulumab | 945781-29-3 |
| Concizumab | Concizumab | 1312299-39-0 |
| Tarextumab | Tarextumab | 1359940-55-8 |
| Anifrolumab | Anifrolumab | 1326232-46-5 |
| Emibetuzumab | Emibetuzumab | 1365287-97-3 |
| Lumretuzumab | Lumretuzumab | 1448327-63-6 |
| Tesidolumab | Tesidolumab | 1531594-08-7 |
| Lilotomab | Lilotomab | 1453362-55-4 |
| Ascrinvacumab | Ascrinvacumab | 1463459-96-2 |
| Rovalpituzumab | 洛伐妥珠单抗 | 1613313-01-1 |
| Xentuzumab | 珍妥珠单抗 | 1417158-65-6 |
| Birtamimab | Birtamimab | 1608108-91-3 |
| Rozanolixizumab | 洛利昔珠单抗 | 1584645-37-3 |
| Camrelizumab | Camrelizumab | 1798286-48-2 |
| Lupartumab Amadotin | Lupartumab Amadotin | 1640972-00-4 |
| Gedivumab | Gedivumab | 1807954-17-1 |
| Lacnotuzumab | Lacnotuzumab | 1831128-32-5 |
